Muñoz-Torres M - Search Results

1

Factors Predicting the Response to a Vitamin D-Fortified Milk in Healthy Postmenopausal Women.

Reyes-Garcia R, Garcia-Martin A, Palacios S, Salas N, Mendoza N, Quesada-Charneco M, Fonolla J, Lara-Villoslada F, Muñoz-Torres M. Reyes-Garcia R, et al. Nutrients. 2019 Nov 4;11(11):2641. doi: 10.3390/nu11112641. Nutrients. 2019. PMID: 31689902 Free PMC article. Clinical Trial.

2

[Cathepsin K: biological aspects and therapeutic possibilities].

Reyes García R, Muñoz-Torres M. Reyes García R, et al. Med Clin (Barc). 2008 Jul 12;131(6):218-20. doi: 10.1157/13124608. Med Clin (Barc). 2008. PMID: 18674501 Spanish. No abstract available.

3

Effects of alendronate treatment on serum levels of osteoprotegerin and total receptor activator of nuclear factor kappaB in women with postmenopausal osteoporosis.

Reyes-García R, Muñoz-Torres M, García DF, Mezquita-Raya P, García Salcedo JA, de Dios Luna J. Reyes-García R, et al. Menopause. 2010 Jan-Feb;17(1):140-4. doi: 10.1097/gme.0b013e3181ac0cc1. Menopause. 2010. PMID: 19574937

4

[Medical treatment of primary hyperparathyroidism: role of calcimimetics].

Muñoz Torres M, García Martín A. Muñoz Torres M, et al. Endocrinol Nutr. 2009 Apr;56 Suppl 1:29-34. doi: 10.1016/S1575-0922(09)70853-8. Epub 2009 May 18. Endocrinol Nutr. 2009. PMID: 19627758 Spanish.

5

Serum cathepsin K as a marker of bone metabolism in postmenopausal women treated with alendronate.

Muñoz-Torres M, Reyes-García R, Mezquita-Raya P, Fernández-García D, Alonso G, Luna Jde D, Ruiz-Requena ME, Escobar-Jiménez F. Muñoz-Torres M, et al. Maturitas. 2009 Nov 20;64(3):188-92. doi: 10.1016/j.maturitas.2009.09.011. Epub 2009 Oct 9. Maturitas. 2009. PMID: 19819089

6

Improvement of bone formation biomarkers after 1-year consumption with milk fortified with eicosapentaenoic acid, docosahexaenoic acid, oleic acid, and selected vitamins.

Martin-Bautista E, Muñoz-Torres M, Fonolla J, Quesada M, Poyatos A, Lopez-Huertas E. Martin-Bautista E, et al. Nutr Res. 2010 May;30(5):320-6. doi: 10.1016/j.nutres.2010.05.007. Nutr Res. 2010. PMID: 20579524 Clinical Trial.

7

Osteocalcin and atherosclerosis: a complex relationship.

Reyes García R, Rozas Moreno P, Muñoz-Torres M. Reyes García R, et al. Diabetes Res Clin Pract. 2011 Jun;92(3):405-6. doi: 10.1016/j.diabres.2010.08.019. Epub 2010 Sep 15. Diabetes Res Clin Pract. 2011. PMID: 20832889

8

Osteocalcin as a marker of metabolic risk in healthy postmenopausal women.

García-Martín A, Cortés-Berdonces M, Luque-Fernández I, Rozas-Moreno P, Quesada-Charneco M, Muñoz-Torres M. García-Martín A, et al. Menopause. 2011 May;18(5):537-41. doi: 10.1097/gme.0b013e3181f8565e. Menopause. 2011. PMID: 21178793

9

[ACTH-independent macronodular adrenal hyperplasia and subclinical Cushing's syndrome].

Cortés-Berdonces M, Avilés-Pérez MD, García-Martín A, Muñoz-Torres M. Cortés-Berdonces M, et al. Med Clin (Barc). 2012 Feb 4;138(2):89-90. doi: 10.1016/j.medcli.2011.05.003. Epub 2011 Jun 23. Med Clin (Barc). 2012. PMID: 21703642 Spanish. No abstract available.

10

[Cardiovascular disease and bone metabolism].

Reyes-García R, Rozas-Moreno P, Muñoz-Torres M. Reyes-García R, et al. Endocrinol Nutr. 2011 Aug-Sep;58(7):353-9. doi: 10.1016/j.endonu.2011.05.004. Epub 2011 Jul 19. Endocrinol Nutr. 2011. PMID: 21775224 Review. Spanish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

293 results

Search Page

Filters